DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiation.

Saved in:
Bibliographic Details
Title: DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiation.
Authors: Abbotts R; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201., Topper MJ; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, 21231., Biondi C; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201., Fontaine D; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201., Goswami R; Georgetown College, Georgetown University, Washington, DC 20057., Stojanovic L; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201., Choi EY; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201., McLaughlin L; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201., Kogan AA; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201., Xia L; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, 21231., Lapidus R; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201., Mahmood J; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201., Baylin SB; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, 21231; sbaylin@jhmi.edu frassool@som.umaryland.edu., Rassool FV; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201; sbaylin@jhmi.edu frassool@som.umaryland.edu.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201.
Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Nov 05; Vol. 116 (45), pp. 22609-22618. Date of Electronic Publication: 2019 Oct 07.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1091-6490
DOI:10.1073/pnas.1903765116